Top

Published in:

01-12-2003 | Current Opinion

What is the Role of NSAIDs in Pre-emptive Analgesia?

Authors: E. Andrew Ochroch, Issam A. Mardini, Dr Allan Gottschalk

Published in: Drugs | Issue 24/2003

Abstract

NSAIDs inhibit the cyclo-oxygenase enzymes, and decrease peripheral and central prostaglandin production. In addition to reducing the inflammation that accompanies tissue injury, decreasing prostaglandin production attenuates the response of the peripheral and central components of the nervous system to noxious stimuli. Such a reduction in the response to pain can reduce the peripheral and central sensitisation induced by noxious stimuli, and reduce the pain experienced in response to subsequent noxious stimuli. These properties would seem to make NSAIDs ideal drugs to use in a pre-emptive fashion, where analgesics are administered prior to a noxious stimulus, such as surgery, with the expectation that reduction in peripheral and central sensitisation will lead to a decrease of pain.

However, the available perioperative trials of pre-emptive NSAID use have yielded modest or equivocal results, and these may be due, in part, to controversy associated with the definition of pre-emptive analgesia and how to conduct the corresponding clinical trials. Although NSAIDs may have a limited ability by themselves to induce a pre-emptive analgesic effect, the available trials suggest how the perioperative use of these drugs may be made more effective. It is expected that NSAIDs will play an increasing role in multimodal analgesia and pain relief in general.

Yaksh TL, Dirig DM, Malmberg AB. Mechanism of action of nonsteroidal anti-inflammatory drags. Cancer Invest 1998; 16(7): 509–27PubMedCrossRef

Katz J. Pre-emptive analgesia: evidence, current status and future directions. Eur J Anaesthesiol Suppl 1995; 10: 8–13PubMed

Kelly DJ, Ahmad M, Brail SJ. Preemptive analgesia I: physiological pathways and pharmacological modalities [in French]. Can J Anaesth 2001; 48(10): 1000–10PubMedCrossRef

Rainville P, Duncan GH, Price DD, et al. Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science 1997; 277(5328): 968–71PubMedCrossRef

Kehlet H, Dahl JB. The value of “multimodal” or “balanced” analgesia in postoperative pain treatment. Anesth Analg 1993; 77: 1048–56PubMedCrossRef

Willis WD. Role of neurotransmitters in sensitization of pain responses. Ann N Y Acad Sci 2001; 933: 142–56PubMedCrossRef

Church MK, Lowman MA, Robinson C, et al. Interaction of neuropeptides with human mast cells. Int Arch Allergy Appl Immunol 1989; 88(1–2): 70–8PubMedCrossRef

Cohen RH, Perl ER. Contributions of arachidonic acid derivatives and substance P to the sensitization of cutaneous nociceptors. J Neurophysiol 1990; 64(2): 457–64PubMed

Melzack R, Coderre TJ, Katz J, et al. Central neuroplasticity and pathological pain. Ann N Y Acad Sci 2001; 933: 157–74PubMedCrossRef

10.

Levine JD, Fields HL, Basbaum AI. Peptides and the primary afferent nociceptor. J Neurosci 1993; 13(6): 2273–86PubMed

11.

Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24(3): 739–68PubMedCrossRef

12.

Brain SD, Williams TJ, Tippins JR, et al. Calcitonin gene-related peptide is a potent vasodilator. Nature 1985; 313(5997): 54–6PubMedCrossRef

13.

Jenkins DW, Feniuk W, Humphrey PP. Characterization of the prostanoid receptor types involved in mediating calcitonin gene-related peptide release from cultured rat trigeminal neurones. Br J Pharmacol 2001; 134(6): 1296–302PubMedCrossRef

14.

Ottosson A, Edvinsson L. Release of histamine from durai mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 1997; 17(3): 166–74PubMedCrossRef

15.

Dray A. Inflammatory mediators of pain. Br J Anaesth 1995; 75(2): 125–31PubMedCrossRef

16.

Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000; 288(5472): 1765–9PubMedCrossRef

17.

Ossipov MH, Lai J, Malan Jr TP, et al. Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci 2000; 909:12–24PubMedCrossRef

18.

Treede RD, Magerl W. Multiple mechanisms of secondary hyperalgesia. Prog Brain Res 2000; 129: 331–41PubMedCrossRef

19.

Herrero JF, Laird JM, Lopez-Garcia JA. Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol 2000; 61(2): 169–203PubMedCrossRef

20.

McCrory CR, Lindahl SG. Cyclooxygenase inhibition for postoperative analgesia. Anesth Analg 2002; 95(1): 169–76PubMedCrossRef

21.

Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A 2002; 99(21): 13926–31PubMedCrossRef

22.

Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin Invest 2001; 107(12): 1491–5PubMedCrossRef

23.

Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxy-genase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol 2002; 42: 553–83PubMedCrossRef

24.

Yaksh TL. Spinal actions of cyclooxygenase isozyme inhibitors. 9th World Congress on Pain; 2000 Aug 22–27; Vienna. Seattle (WA): IASP Press, 2000: 771–85

25.

Malmberg AB, Yaksh TL. Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthe-tized rats. J Neurosci 1995; 15(4): 2768–76PubMed

26.

Yaksh TL, Malmberg AB. Spinal actions of NSAIDS in blocking spinally mediated hyperalgesia: the role of cyclooxygenase products. Agents Actions Suppl 1993; 41: 89–100PubMed

27.

Yaksh TL, Dirig DM, Conway CM, et al. The acute antihyper-algesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci 2001; 21(16): 5847–53PubMed

28.

Dirig DM, Yaksh TL. In vitro prostanoid release from spinal cord following peripheral inflammation: effects of substance P, NMDA and capsaicin. Br J Pharmacol 1999; 126(6): 1333–40PubMedCrossRef

29.

Dirig DM, Yaksh TL. Spinal synthesis and release of prostanoids after peripheral injury and inflammation. Adv Exp Med Biol 1999; 469: 401–8PubMedCrossRef

30.

Lorenzo AV, Spector R. The distribution of drugs in the central nervous system. Adv Exp Med Biol 1976; 69: 447–61PubMedCrossRef

31.

Bannwarth B, Netter P, Lapicque F, et al. Plasma and cerebrospinal fluid concentrations of indomethacin in humans: relationship to analgesic activity. Eur J Clin Pharmacol 1990; 38(4): 343–6PubMedCrossRef

32.

Bannwarth B, Lapicque F, Pehourcq F, et al. Stereoselective disposition of ibuprofen enantiomers in human cerebrospinal fluid. Br J Clin Pharmacol 1995; 40(3): 266–9PubMedCrossRef

33.

Rice AS, Lloyd J, Bullingham RE, et al. Ketorolac penetration into the cerebrospinal fluid of humans. J Clin Anesth 1993; 5(6): 459–62PubMedCrossRef

34.

Jolliet P, Simon N, Bree F, et al. Blood-to-brain transfer of various oxicams: effects of plasma binding on their brain delivery. Pharm Res 1997; 14(5): 650–6PubMedCrossRef

35.

Ito S, Okuda-Ashitaka E, Minami T. Central and peripheral roles of prostaglandins in pain and their interactions with novel neuropeptides nociceptin and nocistatin. Neurosci Res 2001; 41(4): 299–332PubMedCrossRef

36.

Abram SE, Yaksh TL. Morphine, but not inhalation anesthesia, blocks post-injury facilitation: the role of preemptive suppression of afferent transmission. Anesthesiology 1993; 78(4): 713–21PubMedCrossRef

37.

Kissin I. Preemptive analgesia: why its effect is not always obvious. Anesthesiology 1996; 84(5): 1015–9PubMedCrossRef

38.

Kissin I. Preemptive analgesia. Anesthesiology 2000; 93(4): 1138–43PubMedCrossRef

39.

Kissin I. Preemptive analgesia. In: Devor M, Rowbotham DJ, Wiesenfeld-Hallin Z, editors. How can we make it work? Seattle (WA): IASP Press, 2000: 973–85

40.

Katz J. Pre-emptive analgesia: importance of timing. Can J Anaesth 2001; 48(2): 105–14PubMedCrossRef

41.

Katz J. Preemptive analgesia: where do we go from here? J Pain 2000; 1: 89–92

42.

Moiniche S, Kehlet H, Dahl JB. A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief: the role of timing of analgesia. Anesthesiology 2002; 96(3): 725–41PubMedCrossRef

43.

Hogan QH. No preemptive analgesia: is that so bad? Anesthesiology 2002; 96(3): 526–7PubMedCrossRef

44.

Kehlet H. Postoperative pain relief: what is the issue? Br J Anaesth 1994; 72(4): 375–8PubMedCrossRef

45.

Kelly DJ, Ahmad M, Brull SJ. Preemptive analgesia II: recent advances and current trends [in French]. Can J Anaesth 2001; 48(11): 1091–101PubMedCrossRef

46.

Anonymous. Pain terms: a list with definitions and notes on usage: recommended by the IASP Subcommittee on Taxonomy. Pain 1979; 6 (3): 249

47.

Banos JE, Bosch F, Canellas M, et al. Acceptability of visual analogue scales in the clinical setting: a comparison with verbal rating scales in postoperative pain. Methods Find Exp Clin Pharmacol 1989; 11(2): 123–7PubMed

48.

Carlsson AM. Assessment of chronic pain: I, aspects of the reliability and validity of the visual analogue scale. Pain 1983; 16(1): 87–101PubMedCrossRef

49.

Collins SL, Moore RA, McQuay HJ. The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 1997; 72(1–2): 95–7PubMedCrossRef

50.

Liu WH, Aitkenhead AR. Comparison of contemporaneous and retrospective assessment of postoperative pain using the visual analogue scale. Br J Anaesth 1991; 67(6): 768–71PubMedCrossRef

51.

Price DD, McGrath PA, Rafii A, et al. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17(1): 45–56PubMedCrossRef

52.

Serlin RC, Mendoza TR, Nakamura Y, et al. When is cancer pain mild, moderate or severe?: grading pain severity by its interference with function. Pain 1995; 61(2): 277–84PubMedCrossRef

53.

Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983; 17(2): 197–210PubMedCrossRef

54.

Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23(2): 129–38PubMed

55.

Kuch K. Psychological factors and the development of chronic pain. Clin J Pain 2001; 17 (4 Suppl.): S33–8PubMedCrossRef

56.

Blackburn-Munro GB-MR. Psychological factors and the development of chronic pain. J Neuroendocrinol 2001; 13(12): 1009–23PubMedCrossRef

57.

McHorney CA, Ware Jr JE, Lu JF, et al. The MOS 36-item Short-Form Health Survey (SF-36): III, tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994; 32(1): 40–66PubMedCrossRef

58.

McHorney CA, Haley SM, Ware Jr JE. Evaluation of the MOS SF-36 Physical Functioning Scale (PF-10): II, comparison of relative precision using Likert and Rasch scoring methods. J Clin Epidemiol 1997; 50(4): 451–61PubMedCrossRef

59.

Wagner AK, Gandek B, Aaronson NK, et al. Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51(11): 925–32PubMedCrossRef

60.

Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I, conceptual framework and item selection. Med Care 1992; 30(6): 473–83PubMedCrossRef

61.

Ware Jr JE, Kosinski M, Bayliss MS, et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995; 33 (4 Suppl.): AS264–79PubMedCrossRef

62.

Ware Jr JE, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998; 51(11): 903–12PubMedCrossRef

63.

Ware Jr JE, Snow KK, Kosinski M, et al. SF-36 health survey: manual and interpretation guide. Lincoln (RI): Quality Metric Inc, 2000

64.

Ochroch EA, Gottschalk A, Augostides J, et al. A randomized study of long-term pain and activity during recovery from major thoracotomy using thoracic epidural analgesia. Anesthesiology 2002; 97: 1234–44PubMedCrossRef

65.

Flath RK, Hicks ML, Dionne RA, et al. Pain suppression after pulpectomy with preoperative flurbiprofen. J Endod 1987; 13(7): 339–47PubMedCrossRef

66.

Sisk AL, Mosley RO, Martin RP. Comparison of preoperative and postoperative diflunisal for suppression of postoperative pain. J Oral Maxillofac Surg 1989; 47(5): 464–8PubMedCrossRef

67.

Sisk AL, Grover BJ. A comparison of preoperative and postoperative naproxen sodium for suppression of postoperative pain. J Oral Maxillofac Surg 1990; 48(7): 674–8PubMedCrossRef

68.

Vogel RI, Desjardins PJ, Major KV. Comparison of presurgical and immediate postsurgical ibuprofen on postoperative periodontal pain. J Periodontol 1992; 63(11): 914–8PubMedCrossRef

69.

Bridgman JB, Gillgrass TG, Zacharias M. The absence of any pre-emptive analgesic effect for non-steroidal anti-inflammatory drugs. Br J Oral Maxillofac Surg 1996; 34(5): 428–31PubMedCrossRef

70.

Ashworth HL, Ong C, Seed PT, et al. The influence of timing and route of administration of intravenous ketorolac on analgesia after hand surgery. Anaesthesia 2002; 57(6): 535–9PubMedCrossRef

71.

Nelson WE, Henderson RC, Almekinders LC, et al. An evaluation of pre- and postoperative nonsteroidal antiinflammatory drugs in patients undergoing knee arthroscopy: a prospective, randomized, double-blinded study. Am J Sports Med 1993; 21(4): 510–6PubMedCrossRef

72.

Sandin R, Sternlo JE, Stam H, et al. Diclofenac for pain relief after arthroscopy: a comparison of early and delayed treatment. Acta Anaesthesiol Scand 1993; 37(8): 747–50PubMedCrossRef

73.

Reuben SS, Bhopatkar S, Maciolek H, et al. The preemptive analgesic effect of rofecoxib after ambulatory arthroscopic knee surgery. Anesth Analg 2002; 94(1): 55–9PubMed

74.

Bunemann L, Thorshauge H, Herlevsen P, et al. Analgesia for outpatient surgery: placebo versus naproxen sodium (a nonsteroidal anti-inflammatory drug) given before or after surgery. Eur J Anaesthesiol 1994; 11(6): 461–4PubMed

75.

Norris A, Un V, Chung F, et al. When should diclofenac be given in ambulatory surgery: preoperatively or postoperatively? J Clin Anesth 2001; 13(1): 11–5PubMedCrossRef

76.

Nordbladh I, Ohlander B, Bjorkman R. Analgesia in tonsillectomy: a double-blind study on pre and post-operative treatment with diclofenac. Clin Otolaryngol 1991; 16(6): 554–8PubMedCrossRef

77.

Kokki H, Salonen A. Comparison of pre- and postoperative administration of ketoprofen for analgesia after tonsillectomy in children. Paediatr Anaesth 2002; 12(2): 162–7PubMedCrossRef

78.

Romsing J, Ostergaard D, Walther-Larsen S, et al. Analgesic efficacy and safety of preoperative versus postoperative ketorolac in paediatric tonsillectomy. Acta Anaesthesiol Scand 1998; 42(7): 770–5PubMedCrossRef

79.

Salonen A, Kokki H, Tuovinen K. IV ketoprofen for analgesia after tonsillectomy: comparison of pre- and post-operative administration. Br J Anaesth 2001; 86(3): 377–81PubMedCrossRef

80.

O’Hanlon DM, Thambipillai T, Colbert ST, et al. Timing of pre-emptive tenoxicam is important for postoperative analgesia. Can J Anaesth 2001; 48(2): 162–6PubMedCrossRef

81.

Colbert ST, O’Hanlon DM, McDonnell C, et al. Analgesia in day case breast biopsy: the value of pre-emptive tenoxicam. Can J Anaesth 1998; 45(3): 217–22PubMedCrossRef

82.

Chan A, Dore CJ, Ramachandra V. Analgesia for day surgery: evaluation of the effect of diclofenac given before or after surgery with or without bupivacaine infiltration. Anaesthesia 1996; 51(6): 592–5PubMedCrossRef

83.

Buggy DJ, Wall C, Carton EG. Preoperative or postoperative diclofenac for laparoscopic tubal ligation. Br J Anaesth 1994; 73(6): 767–70PubMedCrossRef

84.

O’Hanlon JJ, Muldoon T, Lowry D, et al. Improved postoperative analgesia with preoperative piroxicam. Can J Anaesth 1996; 43(2): 102–5PubMedCrossRef

85.

Cabell CA. Does ketorolac produce preemptive analgesic effects in laparoscopic ambulatory surgery patients? AANA Js 2000; 68(4): 343–9PubMed

86.

Norman PH, Daley MD, Lindsey RW. Preemptive analgesic effects of ketorolac in ankle fracture surgery. Anesthesiology 2001; 94(4): 599–603PubMedCrossRef

87.

Fletcher D, Zetlaoui P, Monin S, et al. Influence of timing on the analgesic effect of intravenous ketorolac after orthopedic surgery. Pain 1995; 61(2): 291–7PubMedCrossRef

88.

Gabbott DA, Cohen AM, Mayor AH, et al. The influence of timing of ketorolac administration on post-operative analgesic requirements following total abdominal hysterectomy. Eur J Anaesthesiol 1997; 14(6): 610–5PubMedCrossRef

89.

Parke TJ, Lowson SM, Uncles DR, et al. Pre-emptive versus post-surgical administration of ketorolac for hysterectomy. Eur J Anaesthesiol 1995; 12(6): 549–53PubMed

90.

Castiglione G, Hauf ME, Panascia E, et al. Does the preoperative administration of ketorolac improve postoperative analgesia. Minerva Anestesiol 1997; 63(7–8): 237–43PubMed

91.

Likar R, Krumpholz R, Mathiaschitz K, et al. The preemptive action of ketoprofen: randomized, double-blind study with gynecologic operations. Anaesthesist 1997; 46(3): 186–90PubMedCrossRef

92.

Likar R, Krumpholz R, Pipam W, et al. Randomized, double-blind study with ketoprofen in gynecologic patients: preemptive analgesia study following the Brevik-Stubhaug design. Anaesthesist 1998; 47(4): 303–10PubMedCrossRef

93.

Murphy DF, Medley C. Preoperative indomethacin for pain relief after thoracotomy: comparison with postoperative indomethacin. Br J Anaesth 1993; 70(3): 298–300PubMedCrossRef

94.

Cronstein BN. Cyclooxygenase-2-selective inhibitors: translating pharmacology into clinical utility. Cleve Clin J Med 2002; 69 Suppl. 1: SI13–9PubMedCrossRef

95.

Mather LE. Do the pharmacodynamics of the nonsteroidal anti-inflammatory drugs suggest a role in the management of postoperative pain? Drugs 1992; 44 Suppl. 5: 1–12PubMedCrossRef

96.

Melzack R. The challenge of pain. 2nd ed. New York: Basic Books, 1998

97.

Hennekens CHJB. Epidemiology in medicine. Boston (MA): Little, Brown and Co, 1987

98.

Dajczman E, Gordon A, Kreisman H, et al. Long-term postthoracotomy pain. Chest 1991; 99(2): 270–4PubMedCrossRef

99.

Jin F, Chung F. Multimodal analgesia for postoperative pain control. J Clin Anesth 2001; 13(7): 524–39PubMedCrossRef

100.

Wall PD. The prevention of postoperative pain. Pain 1988; 33(3): 289–90PubMedCrossRef

101.

Holthusen H, Backhaus P, Boeminghaus F, et al. Preemptive analgesia: no relevant advantage of preoperative compared with postoperative intravenous administration of morphine, ketamine, and clonidine in patients undergoing transperitoneal tumor nephrectomy. Reg Anesth Pain Med 2002; 27(3): 249–53PubMed

102.

Farrar MW, Lerman J. Novel concepts for analgesia in pediatric surgical patients: cyclo-oxygenase-2 inhibitors, alpha 2-agonists, and opioids. Anesthesiol Clin N Am 2002; 20(1): 59–82CrossRef

103.

Tverskoy M, Oz Y, Isakson A, et al. Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia. Anesth Analg 1994; 78(2): 205–9PubMedCrossRef

104.

Tverskoy M, Oren M, Vaskovich M, et al. Ketamine enhances local anesthetic and analgesic effects of bupivacaine by peripheral mechanism: a study in postoperative patients. Neurosci Lett 1996; 215(1): 5–8PubMedCrossRef

105.

Russell MW, Jobes D. What should we do with aspirin, NSAIDs, and glycoprotein-receptor inhibitors? Int Anesthesiol Clin 2002; 40(2): 63–76PubMedCrossRef

Title: What is the Role of NSAIDs in Pre-emptive Analgesia?
Authors: E. Andrew Ochroch
Issam A. Mardini
Dr Allan Gottschalk
Publication date: 01-12-2003
Publisher: Springer International Publishing
Published in: Drugs / Issue 24/2003
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI: https://doi.org/10.2165/00003495-200363240-00002

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

What is the Role of NSAIDs in Pre-emptive Analgesia?

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 24/2003

Excessive Daytime Sleepiness and Sleep Disturbances in Patients with Neurological Diseases

Enfuvirtide

Basiliximab

Clinical Pharmacology of Proton Pump Inhibitors

Enfuvirtide

Levofloxacin